Staar Surgical (STAA) just unveiled an announcement.
STAAR Surgical Company is set to engage investors with presentations starting March 18, 2024, showcasing their success in selling over three million Implantable Collamer® Lenses worldwide. The company’s significant milestone in product distribution underscores its growing influence in the market and positions it as a noteworthy entity for potential investors and market watchers.
Learn more about STAA stock on TipRanks’ Stock Analysis page.